These ESR1 fusions transcripts, ESR1-e6>YAP1 and ESR1-e6>PCDH11X, were identified in patients with metastatic ER+ breast tumors that were pan-endocrine therapy resistant[75]. This evidence concerns the gene ESR1 and breast neoplasm.